Taiho Oncology, Inc.’s Post

Our oncology team is presenting new data in high-risk EGFR+ non-small cell lung cancer (NSCLC) at the American Society of Clinical Oncology (ASCO).   At Johnson & Johnson Innovative Medicine, we believe that all patients deserve to receive advanced, personalized care early in the treatment journey—especially those patients who have disease with high-risk features. We are driving advancement in the front-line treatment of EGFR-mutated NSCLC with the goal of delivering the highest standard of care for patients. To read more about these data, view the press release here: https://bit.ly/4e9E9QQ     #MyCompany #LungCancer #Oncology #CancerResearch #NSCLC

On World Lung Cancer Day, we join the global community in raising awareness about a disease we know all too well. Advancing and accelerating oncology research is core to who we are. See Precision experts in action in an international Phase 1 trial for NSCLC: https://hubs.ly/Q02JJG1h0 #oncology #clinicaltrials #clinicalresearch

❗️ Last chance to register for today’s webinar – Spotlight on antibody–drug conjugates in cancer ❗️ Join Fabrice Barlesi and DIERAS Véronique from 17:30–19:00 (CET) as they discuss the mechanism of action of ADCs as well as the key efficacy and safety data from clinical trials in breast and lung cancer. Our expert panel will also explore current challenges and future directions, such as combining ADCs with other agents. Reserve your place now: https://lnkd.in/ebQfYb52 #ADCs #antibodydrugconjugates #oncology #oncologist #breastcancer #lungcancer #meded #medicaleducation

This March, during Colorectal Cancer Awareness Month, we're focused on raising awareness. Colorectal cancer ranks as the third most common cancer in the United States for both men and women. However, early detection and prevention strategies significantly increase treatment success rates. Follow us this week as Philip Marjon, M.D., M.S. from cCARE - California Cancer Associates for Research & Excellence, an expert in Medical Oncology/Hematology discusses crucial aspects of colorectal cancer awareness, including prevention, screening, and treatment. Watch below to learn about colorectal cancer prevention.

🎗️ This July, we recognize Sarcoma & Bone Cancer Awareness Month, a critical time for the oncology community to rally around sarcoma patients. According to AACR's 2024 estimates, approximately 13,590 cases of soft tissue sarcoma and 3,970 cases of bone and joint cancer will be diagnosed in the U.S. These numbers highlight the urgent need for early detection and advanced treatment strategies. As the Voice of Oncology in Florida, let's raise awareness about sarcoma and bone cancer, advocate for research advancements, and ensure every patient receives personalized care. How can FLASCO enhance outcomes for sarcoma and bone cancer patients? Start a discussion on DocMatter (https://lnkd.in/ehAgQf89) today! #SarcomaAwareness #OncologyCare #ResearchAdvancements #OncologyInnovation #PatientOutcomes

TODAY! FREELIVE WEBINAR! #ADCs - how do they work? What data do we have so far? Treatment challenges? Future directions? Chance to hear from this expert panel, ask your questions, and improve patient care. This should be a good one #meded #oncology #medicaleducation #cme #ime

Ovarian Cancer Research Alliance hosted a discussion during our spring Industry Council meeting that offered insight around the opportunities of broadening the focus among stakeholders from a single gynecologic cancer to all gynecologic cancers, with perspectives shared by clinicians, patient advocates, industry partner GSK, and others. Read a meeting recap and learn more about our Industry Council at bit.ly/4bDqtMA. #GynecologicOncology #Oncology #CancerResearch

🚀 ASCO 2024 In Depth: Dr Elisa Agostinetto and Prof Dr Laurence Buisseret from the Institut Jules Bordet discuss the updated results of the DESTINY-Breast 03 study. The trial confirms T-DXd as a preferred second-line treatment for HER2-positive metastatic breast cancer, showing significant improvements in progression-free survival and overall survival. Learn more about the future potential of T-DXd and ADCs in breast cancer treatment. Discover these updates.👇 For all ASCO 2024 videos, find the link in the comments! #MediMix #ASCO2024 #BreastCancer #OncologyInnovation #DESTINYBreast03

Equip your team with the insight they need to make decisions. Stay competitive with Oncology Resource Group's Pipeline Strategies Reports. Endometrial cancer is evolving fast with a flurry of new approvals, including two this month. ONCrg stays on top of the news, big and small, to save you time. Contact Brittany Daggett to see more of our ONCrg Pipeline Strategies: Endometrial Cancer report, or for other solid tumors, hematologic malignancies, and MOAs. Unrivaled Insights, Unmatched Expertise #oncology #competitivestrategy #endometrialcancer #competitivelandscape

Big ups to Russell C. Langan, MD, FACS, FSSO and RWJBarnabas Health for winning the 14th annual ACCC Innovator Awards which recognize visionary and compelling ideas in oncology from the ACCC! “In the 2 years following program implementation, 82 pancreatic cancers were detected from incidental findings with 65% of patients being diagnosed in earlier stages (stages I, II, and III), as well as instances of ampullary cancer, gallbladder cancer, and gastric cancer.” #defydisease https://lnkd.in/geeHnxAQ